Haleon PLC closed 11.49% below its 52-week high of £4.20, which the company reached on May 30th.

The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022.

Haleon HLN-0.75 % decrease; red down pointing triangle posted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year.

Haleon PLC closed 9.92% short of its 52-week high of £4.20, which the company achieved on May 30th.

Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022. Under the deal, the ...

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

Maker of Sensodyne, Advil, and TUMS becomes one of the world's leading independent consumer health companies Demerger from GSK plc (GSK) now complete WARREN, N.J., July 18, 2022 /PRNewswire ...

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia.The modernization will enable the company to expand ...

Haleon (HLN) announces the appointment of Joe Sta-Romana as Chief Customer Officer, CCO for its US business, effective December 1, 2024. In this role, Joe will lead the organization’s customer ...

Haleon becomes the world’s biggest standalone consumer health business, ... The signature will appear with the logo when space allows as it underscores the purpose of Haleon, the company said.

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product ...